.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
UBS
Covington
US Department of Justice
Harvard Business School
Cantor Fitzgerald
Citi
US Army
Argus Health
Federal Trade Commission

Generated: December 16, 2017

DrugPatentWatch Database Preview

Stavudine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for stavudine and what is the scope of stavudine freedom to operate?

Stavudine
is the generic ingredient in three branded drugs marketed by Bristol Myers Squibb, Aurobindo Pharma, Hetero Labs Ltd Iii, Mylan, Mylan Labs Ltd, and Cipla Ltd, and is included in nine NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for stavudine. Nine suppliers are listed for this compound. There are ten tentative approvals for this compound.

Medical Subject Heading (MeSH) Categories for stavudine

Tentative approvals for STAVUDINE

Applicant Application No. Strength Dosage Form
u► Subscribe40MG; 150MG; 200MGTABLET; ORAL
u► Subscribe40MG; 150MGTABLET; ORAL
u► Subscribe40MG; 150MG; 200MGTABLET; ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo PharmaSTAVUDINEstavudineCAPSULE;ORAL077672-002Dec 29, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd IiiSTAVUDINEstavudineCAPSULE;ORAL078957-001Dec 29, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo PharmaSTAVUDINEstavudineCAPSULE;ORAL077672-001Dec 29, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo PharmaSTAVUDINEstavudineCAPSULE;ORAL077672-004Dec 29, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd IiiSTAVUDINEstavudineCAPSULE;ORAL078957-002Dec 29, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo PharmaSTAVUDINEstavudineCAPSULE;ORAL077672-003Dec 29, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Bristol Myers SquibbZERIT XRstavudineCAPSULE, EXTENDED RELEASE;ORAL021453-002Dec 31, 2002DISCNNoNo► Subscribe► SubscribeY► Subscribe
Hetero Labs Ltd IiiSTAVUDINEstavudineCAPSULE;ORAL078957-003Dec 29, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Bristol Myers SquibbZERIT XRstavudineCAPSULE, EXTENDED RELEASE;ORAL021453-003Dec 31, 2002DISCNNoNo► Subscribe► SubscribeY► Subscribe
Mylan Labs LtdSTAVUDINEstavudineCAPSULE;ORAL078775-001Jan 5, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: stavudine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol Myers SquibbZERITstavudineCAPSULE;ORAL020412-003Jun 24, 1994► Subscribe► Subscribe
Bristol Myers SquibbZERIT XRstavudineCAPSULE, EXTENDED RELEASE;ORAL021453-001Dec 31, 2002► Subscribe► Subscribe
Bristol Myers SquibbZERITstavudineCAPSULE;ORAL020412-004Jun 24, 1994► Subscribe► Subscribe
Bristol Myers SquibbZERITstavudineCAPSULE;ORAL020412-005Jun 24, 1994► Subscribe► Subscribe
Bristol Myers SquibbZERITstavudineCAPSULE;ORAL020412-002Jun 24, 1994► Subscribe► Subscribe
Bristol Myers SquibbZERIT XRstavudineCAPSULE, EXTENDED RELEASE;ORAL021453-004Dec 31, 2002► Subscribe► Subscribe
Bristol Myers SquibbZERITstavudineFOR SOLUTION;ORAL020413-001Sep 6, 1996► Subscribe► Subscribe
Bristol Myers SquibbZERITstavudineCAPSULE;ORAL020412-001Jun 24, 1994► Subscribe► Subscribe
Bristol Myers SquibbZERIT XRstavudineCAPSULE, EXTENDED RELEASE;ORAL021453-003Dec 31, 2002► Subscribe► Subscribe
Bristol Myers SquibbZERIT XRstavudineCAPSULE, EXTENDED RELEASE;ORAL021453-002Dec 31, 2002► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Novartis
Citi
Daiichi Sankyo
Julphar
QuintilesIMS
US Department of Justice
Accenture
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot